Nov 20, 2025 • Benzinga
SOMEWHAT-BULLISH
AGL Investor News: If You Have Suffered Losses in agilon health, inc. ( NYSE: AGL ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Agilon Health ( NYSE:AGL )
NEW YORK, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. ( NYSE:AGL ) resulting from allegations that agilon health may have issued materially ...
Nov 18, 2025 • Benzinga
NEUTRAL
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations - Agilon Health ( NYSE:AGL ) , Coty ( NYSE:COTY )
NEW YORK, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. ( NYSE:AGL ) , Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) , AVITA Medical, Inc. ( NASDAQ:RCEL ) , and Coty, ...
Nov 18, 2025 • Business Insider
SOMEWHAT-BULLISH
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation ...
Nov 10, 2025 • Benzinga
NEUTRAL
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm - Agilon Health ( NYSE:AGL ) , Coty ( NYSE:COTY )
NEW YORK, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. ( NYSE:AGL ) , Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) , AVITA Medical, Inc. ( NASDAQ:RCEL ) , and Coty, ...
Nov 06, 2025 • Benzinga
NEUTRAL
Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of agilon health, inc. - AGL - Agilon Health ( NYSE:AGL )
MIAMI, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Shamis & Gentile, P.A. is investigating whether certain directors and officers of agilon health, inc. ( NYSE:AGL ) breached their fiduciary duties owed to the company.
Nov 04, 2025 • Zacks Commentary
NEUTRAL
Agilon Health ( AGL ) Reports Q3 Loss, Tops Revenue Estimates
Agilon (AGL) delivered earnings and revenue surprises of -50.00% and +0.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?